论文部分内容阅读
目的:探讨雷贝拉唑联合西沙必利对功能性消化不良的应用效果。方法:选择2015年3月-2017年3月期间我院收治的功能性消化不良患者46例为研究对象,均分为对照组和观察组,分别应用奥美拉唑和雷贝拉唑联合西沙必利治疗,对比两组患者治疗前后各项症状变化情况。结果:治疗后,两组患者的各项症状明显好于治疗前,观察组好于对照组,统计学存在比较意义(P<0.05)。结论:雷贝拉唑联合西沙必利对功能性消化不良的应用效果显著,患者的生活质量和症状得到显著改善,值得推广应用。
Objective: To investigate the effect of rabeprazole and cisapride on functional dyspepsia. Methods: Forty-six patients with functional dyspepsia treated in our hospital from March 2015 to March 2017 were selected as the control group and observation group. Omeprazole and rabeprazole were respectively used in combination with Xisha Will be treated, compared two groups of patients before and after treatment of the symptoms of changes. Results: After treatment, the symptoms of both groups were significantly better than before treatment, and the observation group was better than the control group, statistically significant (P <0.05). Conclusion: Rabeprazole combined with cisapride has a significant effect on functional dyspepsia, and the quality of life and symptoms of patients have been significantly improved, which is worth popularizing and applying.